UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Case report: Up‐front allogeneic stem cell transplantation in a patient with the VEXAS syndrome

British journal of haematology, 2022-11, Vol.199 (3), p.e12-e15

2022

Volltextzugriff (PDF)

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis

The Lancet. Haematology, 2017-04, Vol.4 (4), p.e183-e191

2017

Volltextzugriff (PDF)

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

The Lancet. Haematology, 2017-04, Vol.4 (4), p.e183-e191

2017

Volltextzugriff (PDF)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2651-2655

2021

Volltextzugriff (PDF)

High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis

HemaSphere, 2022-11, Vol.6 (11), p.e793-n/a

2022

Volltextzugriff (PDF)

Prospects and limitations of T cell receptor gene therapy

Current gene therapy, 2011-08, Vol.11 (4), p.276-287

2011

Volltextzugriff (PDF)

NK Cells and γδT Cells for Relapse Protection after Allogeneic Hematopoietic Cell Transplantation (HCT)

Current stem cell reports, 2017-12, Vol.3 (4), p.301-311

2017

Volltextzugriff (PDF)

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation

CPT: pharmacometrics and systems pharmacology, 2020-05, Vol.9 (5), p.272-281

2020

Volltextzugriff (PDF)

Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia

Bone marrow transplantation (Basingstoke), 2024-01, Vol.59 (1), p.34-40

2024

Volltextzugriff (PDF)

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

Nature medicine, 2010-05, Vol.16 (5), p.565-570

2010

Volltextzugriff (PDF)

Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series

Journal of neurology, 2024-07, Vol.271 (7), p.4028-4038

2024

Volltextzugriff (PDF)

Graft engineering: how long can you wait, how low can you go, and pandemic readiness

Bone marrow transplantation (Basingstoke), 2023-07, Vol.58 (7), p.820-822

2023

Volltextzugriff (PDF)

Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis

Bone marrow transplantation (Basingstoke), 2023-08, Vol.58 (8), p.956-958

2023

Volltextzugriff (PDF)

Targeting self-antigens through allogeneic TCR gene transfer

Blood, 2006-08, Vol.108 (3), p.870-877

2006

Volltextzugriff (PDF)

Orchestrating an immune response against cancer with engineered immune cells expressing alpha beta TCRs, CARs, and innate immune receptors: an immunological and regulatory challenge

Cancer Immunology, Immunotherapy, 2015-07, Vol.64 (7), p.893-902

2015

Volltextzugriff (PDF)

αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies

Blood advances, 2021-01, Vol.5 (1), p.240-249

2021

Volltextzugriff (PDF)

Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists’ experiences and perspectives

Clinical nutrition ESPEN, 2023-10, Vol.57, p.399-409

2023

Volltextzugriff (PDF)

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge

Cancer Immunology, Immunotherapy, 2015-07, Vol.64 (7), p.893-902

2015

Volltextzugriff (PDF)

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Blood advances, 2024-04, Vol.8 (7), p.1683-1686

2024

Volltextzugriff (PDF)

Requirements for Effective Antitumor Responses of TCR Transduced T Cells

The Journal of immunology (1950), 2008-10, Vol.181 (7), p.5128-5136

2008

Volltextzugriff (PDF)

The next step toward GMP-grade production of engineered immune cells

Oncoimmunology, 2016-02, Vol.5 (2), p.e1076608-e1076608

2016

Volltextzugriff (PDF)

Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy

Biology of blood and marrow transplantation, 2018-06, Vol.24 (6), p.1152-1162

2018

Volltextzugriff (PDF)

TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation

The Journal of immunology (1950), 2008-08, Vol.181 (4), p.2563-2571

2008

Volltextzugriff (PDF)

T-cell receptor gene therapy of established tumors in a murine melanoma model

Journal of immunotherapy, 2008-01, Vol.31 (1), p.1-6

2008

Volltextzugriff (PDF)

An Inducible Caspase 9 Safety Switch Can Halt Cell Therapy-Induced Autoimmune Disease

The Journal of immunology (1950), 2008-05, Vol.180 (9), p.6365-6373

2008

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Case report: Up‐front allogeneic stem cell transplantation in a patient with the VEXAS syndrome

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT

High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis

Prospects and limitations of T cell receptor gene therapy

NK Cells and γδT Cells for Relapse Protection after Allogeneic Hematopoietic Cell Transplantation (HCT)

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation

Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series

Graft engineering: how long can you wait, how low can you go, and pandemic readiness

Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis

Targeting self-antigens through allogeneic TCR gene transfer

Orchestrating an immune response against cancer with engineered immune cells expressing alpha beta TCRs, CARs, and innate immune receptors: an immunological and regulatory challenge

αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies

Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists’ experiences and perspectives

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Requirements for Effective Antitumor Responses of TCR Transduced T Cells

The next step toward GMP-grade production of engineered immune cells

Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy

TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation

T-cell receptor gene therapy of established tumors in a murine melanoma model

An Inducible Caspase 9 Safety Switch Can Halt Cell Therapy-Induced Autoimmune Disease

Suchergebnisse filtern